Dr. Lisa Nolan has been in the healthcare business for over twenty years in multiple functions including business development, strategic planning, marketing and clinical research. Most recently she was Chief Business Officer with Topigen Pharmaceuticals and was instrumental in the sale of the company to Pharmaxis Ltd in 2010. Prior to that she was Vice President of Business Development and Strategic Marketing for Skyepharma PLC, a specialty pharma company focused on innovative drug delivery technologies where she led numerous partnering transactions with US and international companies.
Dr. Nolan also held senior positions in business development, strategic planning and marketing management at West Pharmaceutical Services, Elan Corporation and Zeneca Pharmaceuticals. She is a pharmacist and has a PhD in Clinical Pharmacology.
